Cargando…
Dose Finding in Oncology: What is Impeding Coming of Age?
After a drug molecule enters clinical trials, there are primarily three levers to enhance probability of success: patient selection, dose selection and choice of combination agents. Of these, dose selection remains an under-appreciated aspect in oncology drug development despite numerous peer-review...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314272/ https://www.ncbi.nlm.nih.gov/pubmed/35474158 http://dx.doi.org/10.1007/s11095-022-03263-5 |